To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalization

To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalization - Intravitreal Bevaxizumab injection for intraocular neovasculalization

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000647

Enrollment

Registered

2007-03-22

Start date

2007-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARMD,BRVO,CRVO,DR,CNV

Interventions

Intravitreal injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatient of Keio University with ARMD,BRVO,CRVO,DR,CNV that are able to examined by angiography or checked retinal thickness.

Exclusion criteria

Exclusion criteria: Cr>3.0mg/dL anstable angina malignant arrhythmia HT:140/80mmHg>

Design outcomes

Primary

Measure	Time frame
To acess side-effect and examin visual acuity,thickness of retina and retinal angiography	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026